Oncogene - Table of Contents alert Volume 35 Issue 30

If you are unable to see the message below, click here to view.

Advertisement First CRISPR/Cas9 antibody validated for chromatin immunoprecipitation A new addition to Diagenode's Cas9 collection!  Recognizes the C-terminus of the Cas9 nuclease  Ideal for fusion protein experiments  Validated in IP, WB and IF  Learn more and get best quality data  TABLE OF CONTENTS Volume 35, Issue 30 (July 2016) In this issue Review Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement View most cited articles — which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage    Review Top Oncogenic PTEN functions and models in T-cell malignancies M Tesio, A Trinquand, E Macintyre and V Asnafi Oncogene 2016 35: 3887-3896; advance online publication, November 30, 2015; 10.1038/onc.2015.462 Abstract | Full Text Original Articles Top Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells P-C Chu, M-C Yang, S K Kulp, S B Salunke, L E Himmel, C-S Fang, A M Jadhav, Y-S Shan, C-T Lee, M-D Lai, L A Shirley, T Bekaii-Saab and C-S Chen Oncogene 2016 35: 3897-3908; advance online publication, November 30, 2015; 10.1038/onc.2015.458 Abstract | Full Text Spontaneous tumor development in bone marrow-rescued DNA-PKcs3A/3A mice due to dysfunction of telomere leading strand deprotection S Zhang, S Matsunaga, Y-F Lin, B Sishc, Z Shang, J Sui, H-Y Shih, Y Zhao, O Foreman, M D Story, D J Chen and B P C Chen Oncogene 2016 35: 3909-3918; advance online publication, November 30, 2015; 10.1038/onc.2015.459 Abstract | Full Text Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis W Yang, W W Du, X Li, A J Yee and B B Yang Oncogene 2016 35: 3919-3931; advance online publication, December 14, 2015; 10.1038/onc.2015.460 Abstract | Full Text Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells T Kimura, L Wang, K Tabu, M Tsuda, M Tanino, A Maekawa, H Nishihara, H Hiraga, T Taga, Y Oda and S Tanaka Oncogene 2016 35: 3932-3943; advance online publication, December 7, 2015; 10.1038/onc.2015.461 Abstract | Full Text CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling S Ventura, D N T Aryee, F Felicetti, A De Feo, C Mancarella, M C Manara, P Picci, M P Colombo, H Kovar, A Carè and K Scotlandi Oncogene 2016 35: 3944-3954; advance online publication, November 30, 2015; 10.1038/onc.2015.463 Abstract | Full Text Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax R Bajpai, S M Matulis, C Wei, A K Nooka, H E Von Hollen, S Lonial, L H Boise and M Shanmugam Oncogene 2016 35: 3955-3964; advance online publication, December 7, 2015; 10.1038/onc.2015.464 Abstract | Full Text Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer R Bharti, G Dey, P K Ojha, S Rajput, S K Jaganathan, R Sen and M Mandal Oncogene 2016 35: 3965-3975; advance online publication, November 30, 2015; 10.1038/onc.2015.466 Abstract | Full Text A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT A Pinto, Y Mace, F Drouet, E Bony, R Boidot, N Draoui, I Lobysheva, C Corbet, F Polet, R Martherus, Q Deraedt, J Rodríguez, C Lamy, O Schicke, D Delvaux, C Louis, R Kiss, A V Kriegsheim, C Dessy, B Elias, J Quetin-Leclercq, O Riant and O Feron Oncogene 2016 35: 3976-3985; advance online publication, December 21, 2015; 10.1038/onc.2015.474 Abstract | Full Text Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival D Dayde, M Guerard, P Perron, A-S Hatat, C Barrial, B Eymin and S Gazzeri Oncogene 2016 35: 3986-3994; advance online publication, December 21, 2015; 10.1038/onc.2015.480 Abstract | Full Text DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment H Yan, G Tang, H Wang, L Hao, T He, X Sun, A H Ting, A Deng and S Sun Oncogene 2016 35: 3995-4008; advance online publication, November 9, 2015; 10.1038/onc.2015.423 Abstract | Full Text RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress N Kanu, T Zhang, R A Burrell, A Chakraborty, J Cronshaw, C DaCosta, E Grönroos, H N Pemberton, E Anderton, L Gonzalez, S Sabbioneda, H D Ulrich, C Swanton and A Behrens Oncogene 2016 35: 4009-4019; advance online publication, November 9, 2015; 10.1038/onc.2015.427 Abstract | Full Text Corrigenda Top RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress N Kanu, T Zhang, R A Burrell, A Chakraborty, J Cronshaw, C DaCosta, E Grönroos, H N Pemberton, E Anderton, L Gonzalez, S Sabbioneda, H D Ulrich, C Swanton and A Behrens Oncogene 2016 35: 4020; advance online publication, June 27, 2016; 10.1038/onc.2015.500 Full Text DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment H Yan, G Tang, H Wang, L Hao, T He, X Sun, A H Ting, A Deng and S Sun Oncogene 2016 35: 4020; advance online publication, June 27, 2016; 10.1038/onc.2016.28 Full Text Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.